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Introduction Methods
The Ames Seralyzer Reflectance Photometer (its UK price in
January 1982 was 2250 plus Value-Added Tax) employs dry
reagent strips and reflectance photometry for the measurement
of several analytes in serum. Reagent strips are currently
available in theUK for the determination ofglucose (kinetically
using glucose oxidase with oxidized 3,3’, 5,5’-tetramethylben-
zidine as the indicator), urea (reaction with o-phthalaldehyde
which, in the acidic environment of a cation exchanger, yields a
blue chromogen) and urate (uricase method yielding a coloured
complex from 3-methyl-2-benzothiazolinone hydrazone and
primaquine diphosphate). Other tests are being developed
[1 and 2].
During analysis, light from a xenon flashtube illuminates an
integrating sphere in a series of flashes. Light within the sphere
strikes all surfaces. The light reflected vertically from the reagent
area passes through a collimator and then through a Test
Module filter to a sample detector. Other reflected light in the
sphere passes through the Test Module filter to a reference
detector. The reference and sample detector signals are con-
verted by a microcomputer to a ratio; the series of reflectance
measurements made during the test period is used to compute
the result from the stored calibration line, and is shown on a
display.
The instrument is neat and compact in appearance (height
140ram, width 280mm, depth 380mm, weight 10kg). After
allowing 20min to warm up, the appropriate Test Module is
inserted, the sphere rehydrated (according to the manufacturer’s
instructions) and the instrument is calibrated for the specified
test by entering the value for the Low Calibrator via the
keyboard. A reagent strip is placed on the Reagent Table and
30 #1 ofLow Calibrator (diluted one in three with distilled water)
is pipetted onto the centre of the reagent area. The ’Start’ key is
pressed immediately, and the Reagent Table pushed in. When
the analysis is complete, a buzzer sounds, the ’Analyze’ light goes
out and the entered calibrator value is displayed. This sequence
is repeated for theHigh Calibrator. An Error Code will indicate
if calibration is unsuccessful. A similar procedure is followed for
specimen analysis: all sera are diluted one in three and 30 #1 is
applied to the reagent strip, the Start key pressed and the
Reagent Table pushed in; the result is displayed when the buzzer
sounds. Over-range specimens are analysed by preparing a
further three-fold dilution and pressing the ’Dil’ key before the
analysis. Any error or instrument malfunction is communicated
via Error Codes on the display.
At the time of the evaluation, Ames stated that the Seralyzer
could only be used for the analysis ofserum, and that specimens
for glucose analysis should not be collected in fluoride as this
would inhibit the reaction in the reagent strip.
The evaluation
The instrument was borrowed from the manufacturer (Ames
Division, Miles Laboratories Ltd, Stoke Court, Stoke Poges,
Slough SL2 1LY, UK) for the evaluation and was installed by
their representative; Ames also provided all the necessary
equipment and reagents for its operation.
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Precision
Three lyophilized quality-control sera with high, medium and
low analyte levels were reconstituted as directed by the manu-
facturer. Three fresh human serum pools were collected with
high, medium and low concentrations of each analyte. Aliquots
of all these sera were analysed 20 times within a single analytical
run (i.e. using a single bottle of the appropriate reagent strips
and within a single calibration period). Aliquots were also stored
at -20C and one of each analysed on 16-20 consecutive
working days.
Linearity
Specimens with high and low analyte concentrations were mixed
in varying proportions to yield specimens with levels covering
the full analytical range for each test. After dilution, each serum
was analysed in duplicate, and further dilutions were made as
necessary.
Effect of dilution
Three sera with high concentrations of each analyte were
analysed on a Technicon SMA 12/60. Each was then diluted
with distilled water and analysed on the Seralyzer, further
dilutions of over-range specimens being made as necessary.
Accuracy
Nine lyophilized sera, which had been circulated through the
United Kingdom National External Quality Assessment
Scheme (UKNEQAS), were analysed on the Seralyzer and the
results for each analyte compared with the mean value for the
appropriate manual method.
Comparison with routine methods
Approximately 100 specimens of serum submitted for routine
analysis were analysed on the Seralyzer and on an SMA 12/60,
which used the following methods: glucose-glucose oxidase;
urea-diacetyl monoxime; and urate-phosphotungstate [3, 4
and 5].
Interferences
The effects of haemolysed erythrocytes on urea analysis, and of
ascorbic acid on urate and glucose analysis, were assessed by the
addition of each, at two concentrations, to three samples of
serum.
Results and discussion
Precision
The results of within- and between-batch precision studies are
given in tables and 2. These show that the coefficient of
variation(C) for glucose ranges from 1.5-7.2% (mean 3-5%), for
urea from 4"3-12.2% (mean 6.4%), and for urate from 2.6-14.3%
(mean 5"9%). These figures may be compared with recom-
mended analytical CVs of 3.0%, 6"0% and 4-1% respectively [6]P. M. S. Clark and P. M. G. Broughton Evaluation of the Ames Seralyzer
Within-batch Between-batch
Analyte Low Medium High Low Medium High
Glucose
(mmol/1)
Urea
(rnmol/l)
Urate
(/mol/1)
Mean 3.9 5"8 11.6 3"6 5"8 13"6
SD 0"06 0"09 0"35 0’ 18 0"20 0"74
CVo 1.5 1"5 3"0 4"8 3"4 5’5
N 20"0 20.0 20"0 20"0 20"0 20"0
Mean 2.4* 6.1 19"1 3"0 6"3 19-2
SD 0.15 0"28 1"23 0"20 0"29 1"34
CVo 6"1 4"6 6"5 6"8 4.7 7"0
N 20"0 20’0 20"0 20"0 20"0 20"0
Mean 132.0 308.0 473"0 105"0 303"0 505"0
SD 6.7 7’9 37"8 15-1 14"6 39-3
CVTo 5-1 2"6 8"0 14.3 4"8 7"8
N 20.0 20"0 20"0 17"0 17"0 17"0
*These results include three values below the analytical range of the instrument and have been taken as
2.1 mmol/l. When recalculated excluding these results" mean 2"5, SD=0" 12 mmol/l and CV 5"0?/0.
Where SD=standard deviation" CV =coefficient of variation; and N=number of replicate analyses.
Table 1. Precision results
for fresh human serum.
Within-batch Between-batch
Pathonorm Ortho- Pathonorm Ortho-
Analyte L Equitrol Abnormal L Equitrol Abnormal
Glucose
(mmol/1)
Urea
(mmol/l)
Urate
(/mol/l)
Mean 2"5 5"8 15"4 2"2* 6"4 15"2
SD 0.05 0.17 0"38 0"16 0"19 0’76
CV 2.0 3.0 2"5 7"2 3"0 5"0
N 20"0 20"0 20"0 20"0 20"0 20"0
Mean 3.5 8.0 19"5 3"7 9"1 19.3
SD 0"43 0"34 0"90 0"26 0’56 1"28
CV% 12.2 4.3 4"6 7-0 6"1 6"7
N 20"0 20"0 20"0 20"0 20"0 20"0
Mean 201.0 346.0 551.0 204.0 370.0 574.0
SD 12-6 15.0 19.0 8"5 18"4 29"2
CVo 6.3 4.3 3.4 4.2 5.0 5-1
N 20.0 20.0 20.0 16"0 16"0 16"0
*These results include two values below the analytical range of the instrument and have been taken as
1.9 mmol/l. When recalculated excluding those results: mean= 2"2, SD=0.13 mmol/1 and CV =6"0?/0.
(Pathonorm L from BDH, Poole, Dorset, UK; Equitrol from Tissue Culture Services, Slough, Berkshire,
OrthoAbnormal from Ortho Diagnostics.)
Table 2. Precision results
for quality-control sera.
and they are not as good as those obtained by other workers [7].
It was concluded that the precision of the Seralyzer was
adequate for some clinical purposes. There was little difference
between the CVs found with fresh human and quality-control
sera. Two high CVs were obtained (urea [see table 2], and urate
[see table 1]), but none of the results for these two experiments
were outside the limits of the mean 3SD. When recalculated,
excluding values outside the limits mean+2SD (one result for
each), the CVs were 10"87/o for urea and 12"1o for urate,
indicating poor precision with these specimens.
Linearity
Polynomial regression analysis ofthe whole data for all analytes
indicated both a significant linear component and a significant
non-linear component. When over-range samples requiring an
additional dilution step were excluded, the linear component
remained but no significant non-linearity was found. This is
illustrated for glucose in figure 1; similar graphs were obtained
for urea and urate. It was concluded that a linear response is
found over the analytical range for all analytes, but some non-
linearity is introduced by dilution of over-range specimens
according to the manufacturer’s recommended procedures.
Effect of dilution
Polynomial regression showed that for glucose there was a
significant non-linear component with over-range samples
requiring further dilution before analysis on the Seralyzer
(figure 2). Urea shows a similar significant non-linear com-
ponent with over-range samples, but urate did not. Considering
the results of the linearity and dilution experiments together, it
was concluded that there is a linear relationship for all three
analytes over the analytical ranges quoted by the manufacturer,
but some non-linearity is introduced when further dilution is
made as recommended by the manufacturer. The fact that
dilution of the original specimen does not introduce non-
linearity (as shown by the linear response in the first part of the
graph shown in figure 2) suggests that the error may be
introduced by the instrumental correction for the additional
dilution step rather than by any changes in the specimen matrix.
Accuracy with control sera
The results given in table 3 show that for the materials studied
the Seralyzer gives results that for glucose are lower and for urea
and urate determinations are higher than those of comparable
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Figure 2. Effect of dilution of specimen on glucose
determinations (Q) sample 1, sample 2, sample 3).
Glucose (mmol/1) Urea (mmol/1) Urate (mmol/1)
Manual method Manual method Manual method
(glucose oxidase) Seralyzer (urease) Seralyzer (uricase) Seralyzer
Mean Mean Mean
Control material Mean N 3 Mean N 3 Mean N 3
Armtrol 489 4"70 (62) 4.33 289 (61) 336
Ortho Abnormal
W24K02B 13"67 (62) 11.20 13"91 (62) 15.13 525 (63) 547
Ortho Abnormal 95317 16.99 (66) 15.53
Pathonorm L18 2"20 (67) 2.17 3"66 (68) 4.00 196 (55) 221
HIQC/4 8.35 (57) 8.10 7’35 (63) 7.60 335 (63) 351
Ortho Normal
W27X02B 5.04 (59) 4.53 5.64 (62) 6.33 236 (63) 240
Liberton L4/80 5.40 (59) 4.97 4.57 (58) 4.40 252 (62) 276
Monitrol IIX
SPXP9613 16.57 (65) 19-10
Armtrol 551 4-51 (63) 3.93 8"87 (61) 9.70 300 (67) 326
Wellcomtrol Two
K9122 10.57 (62) 10.30 27.66 (62) 29.20 492 (72) 554
HIQC/5 7.32 (63) 6.93 6"63 (64) 6.33 235 (73) 236
Table 3. Analysis of
quality-control sera.
Average difference % 8.1 + 7.2 + 8.8
Manual method means were calculated through UKNEQAS, the figures in parentheses being the number ofresults used to
calculate the mean.The manufacturer’s assigned values were given for the following: Pathonorm L= glucose= 2.2 mmol/1;
urea=3.5mmol/l; urate=200#mol/l: HIQC/4=glucose=8.35mmol/1; urea- 7.35 mmol/1; urate=335/mol/l:
HIQC/5 glucose 7.25 mmol/l; urea =6"57 mmol/1; urate= 233/mol/1.
manual methods. Similar results were obtained for urea and
urate, but not glucose, by Thomas and co-workers [7]. There
were no noticeable differences in behaviour between the different
control sera (i.e. no species differences), although one lot of
OrthoAbnormal (W24KO2B) showed large differences between
the Seralyzer and manual glucose methods, and the number of
materials studied was small. However, another lot of this
material showed a smaller difference, close to the average.
Comparisons with routine methods
Graphs showing the comparison between the Seralyzer results
and those obtained by the SMA 12/60 are given in figures 3, 4
and 5. These show that, whilst there is a good correlation
between results found with the two methods for all analytes, the
Seralyzer gives statistically significantly lower results than the
SMA 12/60 methods. For urate and urea, these differences are
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unlikely to be clinically significant, but with glucose the
differences are more important. In addition, the scatter of
results becomes noticeable with over-range specimens requiring
further dilution (i.e. glucose: > 22.2mmol/1; urea> 21 mmol/l;
urate> 600 #mol/1).
Interferences
The results are shown in table 4. Ascorbic acid was found to
interfere significantly with both glucose and urate analyses.
These findings confirm results quoted by the manufacturer.
No details of the effect of haemoglobin on urea analysis are
given in Ames’s instructions, although the manufacturer stated
verbally that it did not interfere. The effect was found to be
variable, with a significant increase at the lower haemoglobin
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Figure 3. Comparison of Seralyzer glucose results with
SMA 12/60 results using human sera (correlation
coefficient 0"98, N 100, y 0.86x+ 0"49).
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Figure 5. Comparison of Seralyzer urate results with
SMA 12/60 results using human sera (correlation
coefficient 0.99, N 99, y= 0.93x 2.83).
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Figure 4. Comparison of Seralyzer urea results with
SMA 12/60 results using human sera (correlation
coefficient 0"99, N 94, y 0"93x+ 0"08).
Table 4. Effects ofadded haemoglobin and ascorbic acid
on urea, glucose and urate analysis.
Level of
Interference interfering Percentage
studied substance Sample change
Haemoglobin 3"8 g/l + 8
on urea 2 NS
3 +17
1.9 g/1
Ascorbic acid 50 mg/l
on glucose
25mg/q
Ascorbic acid 100 mg/1
on urate
50mg/1
+10
2 +6 p<0.01
3 +13
-13
2 -14 p<O"O01
3 -6
-8
2 11 p<O’O1
3 -3
-35
2 -39 p <0"001
3 -37
-29
2 -32 p<0"001
3 -34
Dependability
During the 18-week period of the evaluation, no major faults
developed and relatively few Error Codes occurred. During the
evaluation, recalibration (other than that performed daily, for
new bottles of strips, or when switched on or power cut-off) was
necessary when the reanalysis of calibrators and controls
indicated that either calibrator or control values were outside
the manufacturer’s limits. This occurred 10 times for glucose, 10
times for urea and four times for urate. With glucose and urate
this was because the results for Omega controls fell outside the
limits suggested by Ames. No analytical reason could be found
for this, and inspection of the control graphs showed that urate
results were always high and glucose results low.No explanation
of this was given by the manufacturer, and subsequently
recalibration was only carried out ifthe control values were well
outside these limits.
Instructions
These consist of package inserts, enclosed with each bottle of
reagent strips and each set of calibrators, and an operating
manual. They give a good account ofthe theoretical principles of
the instrument and the chemical reactions used, but in order to
perform the three tests evaluated here, seven items of literature
must be consulted. This is highly repetitive and often confusing,
particularly when some data are given in mg/dl and others in SI
units. Package inserts recommend hydration of the integrating
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sphere every 8 h for glucose, and every 15 min for urea, but this is
not mentioned for urate. Although each calibration by the
analysis of calibrators and controls was checked, as rec-
ommended by the manufacturer’s representative, this is not
mentioned in any ofthe printed instructions, and quality control
receives scant attention or explanation.
Electrical and mechanical construction
Our engineering staff examined the machine without making
rigorous mechanical and electrical tests, and found the Seralyzer
to be basically safe. However, the Reagent Table is easily
contaminated and difficult to clean. Contamination with serum
spilling from the reagent strips, particularly the urea strips, was
frequent--even with an experienced operator. A gap between
the upper and lower cases of the instrument might also allow
some specimen spillage into the instrument.
The colour and texture of the case of the instrument made
contamination difficult to see and so cleaning was difficult. The
keyboard was not easily decontaminated, and a membrane-type
keyboard would therefore be preferable.
Runnin9 costs
The cost of consumables, together with direct labour times [8],
for glucose, urea and urate are given in table 5. This shows that
calibration costs are relatively high with small work-loads, but
the cost per test decreases rapidly for larger work-loads.
However, the operator will then soon become bored, and his
results deteriorate with more than about 50 tests per day. To
obviate this by employing a second operator would further
increase costs.
Conclusions
The Seralyzer is an inexpensive instrument, which is quick and
simple to use, and its performance in measuring serum glucose,
urea and urate is adequate for some clinical purposes. However,
it does have several major disadvantages. It is restricted to the
analysis of serum and cannot measure low glucose levels. All
specimens need predilution and the instrument was found to be
labour-intensive and operator-dependent.
Since the Seralyzer may be used outside the hospital
laboratory, its accuracy is of some concern--particularly with
glucose. With quality-control sera, results for all three analytes
differ considerably from those found with comparable manual
methods. This restricts the ability of the operator to check the
accuracy of his results with commercial quality-control sera. If
he uses materials with assigned values obtained with Seralyzer
methods, he is merely checking one Seralyzer against another.
The user would be unable to check performance of the
instrument with external quality-assessment schemes, which at
present do not quote method-mean values for the Ames
Table 5. Cost of consumables (including Value-Added
Tax) and direct labour time per testfor different daily work-
loads.
Glucose Urea Urate
min min min
Calibration
sequence only
Consumables 2.04 2.04 2"52
Labour 16 14 19
Single test only
Consumables 0"23 0.23 0.31
Labour 2 3 4
Tests per day
Consumables 2.27 2.27 2.83
Labour 18 17 23
5 Consumables 0.63 0.63 0"81
Labour 5.2 5.8 7.8
20 Consumables 0.33 0.33 0.44
Labour 2.8 3.7 5"0
Seralyzer. These factors are particularly important if the instru-
ment is used by staff who are not familiar with quality-control
procedures and, in general, this subject is given inadequate
attention in the manufacturer’s literature.
Although the range of tests possible on the Seralyzer may be
extended in the future, the present limitation ofthe instrument to
glucose, urea and urate measurements is unlikely to make it
useful in hospital laboratories in the UK, particularly as there
are cheaper alternatives available for blood glucose measure-
ments [9]. It might, however, find an application where few
samples need to be analysed quickly, although it must be
emphasized that this will require some skill, dexterity and
acumen.
Acknowledgements
The authors wish to thank the Ames Division of Miles for the
loan of the instrument and for their co-operation during the
evaluation. The financial support of the DHSS is gratefully
acknowledged.
References
GREYSON, J., Journal of Automatic Chemistry, 3 (1981), 66.
ZIPP, A., Journal of Automatic Chemistry, 3 (1981), 71.
TRDFR, P., Annals of Clinical Biochemistry, 6 (1969), 24.
MARCH, W. M., FINGERHUT, B. and MILLER, H., Clinical
Chemistry, 11 (1965), 624.
MUSSER, A. W. and ORTIGOZA, C., Technical Bulletin of
Registered Medical Technicians, 36 (1969), 2125.
STATLAND, B. E., Clinical Biochemistry Reviews, 3 (1982), 1.
THOMAS, L., PLISCHKE, W. and STORZ, G., Annals of Clinical
Biochemistry, 19 (1982), 214.
BROUGHTON, P. M. G. and HOGAN, T. C., Annals of Clinical
Biochemistry, 18 (1981), 330.
WEBB, D. J., LOVESA, J. M., ELLIS, A. and KNIGHT, A. H., British
Medical Journal, 280 (1980), 362.
26